Available Locations
Offering ELIAS Cancer Immunotherapy (ECI®) product requires a Specialty Hospital with oncology capabilities to still be in relative proximity to an apheresis center. ELIAS is currently developing that network, and is available commercially in the following locations (please contact the appropriate Specialty Hospital listed below).
*Indicates hospital is also participating in the current clinical trial. Learn more about the study here.